Up-regulation and functional role of p21(Waf1)/(Cip1) during growth arrest of human breast carcinoma MCF-7 cells by phenylacetate

Cell Growth and Differentiation

Volumn 7, Issue 12, 1996, Pages 1609-1615

  Gorospe, Myriam ^a   Shack, Sonsoles ^a   Guyton, Kathryn Z ^a   Samid, Dvorit ^b   Holbrook, Nikki J ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; PHENYLACETIC ACID; PROTEIN KINASE INHIBITOR; PROTEIN P21; RETINOBLASTOMA PROTEIN;

ANIMAL CELL; ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CANCER INHIBITION; CELL CYCLE; CONTROLLED STUDY; CYTOSTASIS; FIBROBLAST; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; ANTISENSE ELEMENTS (GENETICS); BREAST NEOPLASMS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CDC2-CDC28 KINASES; CELL DIVISION; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASES; CYCLINS; ENZYME INHIBITORS; FEMALE; FIBROBLASTS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MICE, KNOCKOUT; PHENYLACETATES; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; RETINOBLASTOMA PROTEIN; RNA, MESSENGER; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED; UP-REGULATION;

ANIMALIA; MINK CELL FOCUS-FORMING VIRUS;

EID: 0029829031     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Samid, D., Shack, S., and Myers, C. Selective growth arrest and phenotypic reversion of prostate cancer cells in vitro by nontoxic pharmacological concentrations of phenylacetate. J. Clin. Invest., 91: 2288-2295, 1993.
2. Samid, D., Ram, Z., Hudgins, W. R., Shack, S., Liu, L., Walbridge, S., Oldfield, E. H., and Myers, C. E. Selective activity of phenylacetate against malignant gliomas: resemblance to fetal brain damage in phenylketonuria. Cancer Res., 54: 891-895, 1994.
3. Sacks, L. Control of normal cell differentiation and the phenotypic reversion of malignancy in myeloid leukemia. Nature (Lond.), 274: 535-539, 1978.
4. Golomg, H. M., Ratain, M. J., Mick, R., and Daly, K. The treatment of hairy cell leukemia: an update. Leukemia (Baltimore), 6: 24-27, 1992.
5. Momparler, R. L., Rivard, G. E., and Gyger, M. Clinical trial on 5-aza-2-deoxycytidine in patients with acute leukemia. Pharmacol. & Ther., 30: 277-286, 1995.
6. Muindi, J. R., Frankel, S. R., Huselton, C., DeGrazia, F., Garland, W. A., Young, C. W., and Warrell, R. P. J. Clinical pharmacology of oral all-trans-retinoic acid in patients with acute promyelocytic leukemia. Cancer Res., 52: 2138-2142, 1992.
7. Samid, D., Yeh, A., and Prasanna, P. Induction of erythraid differentiation and fetal hemoglobin production in human leukemic cells treated with phenylacetate. Blood, 80: 1576-1581, 1992.
8. Shack, S., Miller, A., Liu, L., Prasanna, P., Thibault, A., and Samid, D. Vulnerability of multidrug-resistant tumor cells to the aromatic fatty acids phenylacetate and phenylbutyrate. Clin. Cancer Res., 2: 865-872, 1996.
9. Weber, G. Biochemical strategy of cancer cells and the design of chemotherapy: G. H. A. memorial lecture. Cancer Res., 43: 3446-3492, 1983.
10. Medina, M. A., Sanchez-Jimenez, F., Markez, F. J., Perez-Rodriguez, J., Quesada, A. R., and Nunez de Castro, I. Glutamine and glucose as energy substrates for ehrlich ascites tumor cells. Biochem. Int., 16: 339-347, 1988.
11. Goldstein, J. L., and Brown, M. S. Regulation of the mevalonate pathway. Nature (Lond.), 343: 425-430, 1990.
12. Bird, A. The essentials of DNA methylation. Cell, 70: 5-8, 1992.
13. Tontonoz, P., Hu, E., and Spiegelman, B. M. Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor. Cell, 79: 1147-1156, 1994.
14. Seger, R., and Krebs, E. G. The MAPK signalling cascade. FASEB J., 9: 726-735, 1995.
15. Morgan, D. O. Principles of CDK regulation. Nature (Lond.), 374; 131-134, 1995.
16. Xiong, Y., Hannon, G. J., Zhang, H., Casso, D., Kobayashi, R., and Beach, D. p21 is a universal inhibitor of cyclin kinases. Nature (Lond.), 366: 701-704, 1993.
17. El-Deiry, W. S., Tokino, T., Velculescu, T., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., and Vogelstein, B. WAF1, a potential mediator of p53 tumor suppression. Cell, 75: 817-825, 1993.
18. 2-mediated growth arrest. Mol. Cell. Biol., 16: 762-770, 1996.
19. WAF1/CIP1 expression through mitogen-activated protein kinase signalling pathway. Cancer Res., 56; 1-5, 1996.
20. Michieli, P., Chedid, M., Lin, D., Pierce, J. H., Mercer, W. E., and Givol, D. Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res., 54: 3391-3395, 1994.
21. CIP1/WAF1 expression by cellular stress: p53-dependent and p53-independent mechanisms. Mol. Cell. Differ., 4: 47-65, 1996.
22. Macleod, K. F., Sherry, N., Hannon, G., Beach, D., Tokino, T., Kinzler, K., Vogelstein, B., and Jacks, T. p53-dependent and independent expression of p21 during cell growth, differentiation and DNA damage. Genes Dev., 9: 935-944, 1995.
23. 0 and entry into the cell cycle of cells expressing p21Sdi1 antisense RNA. Proc. Natl. Acad. Sci. USA, 92: 4352-4356, 1995.
24. Fan, S., Smith, M. L., Rivet, D. J., Duba, D., Zhan, Q., Kohn, K. W., Fornace, A. J., Jr., and O'Connor, P. M. Disruption of p53 function sensitizes breast cancer MCF-7 cells to cisplatin and pentoxifylline. Cancer Res., 55: 1649-1654, 1995.
25. ras isoprenylation and phenotypic reversion. Int. J. Cancer, 63: 124-129, 1995.
26. Zhang, H., Xiong, Y., and Beach, D. Proliferating cell nuclear antigen and p21 are components of multiple cell cycle kinase complexes. Mol. Biol. Cell, 4: 897-906, 1993.
27. Weinberg, R. A. The retinoblastoma protein and cell cycle control. Cell, 81: 323-330, 1995.
28. 2-mediated cellular arrest and death. Cancer Res., 56: 457-479, 1996.
29. Samid, D., Shack, S., and Sherman, L. T. Phenylacetate. A novel nontoxic inducer of tumor cell differentiation. Cancer Res., 52: 1988-1992, 1992.
30. Thibault, A., Samid, D., Cooper, M. R., Figg, W. D., Tompkins, A. C., Patronas, N., Headlee, D. J., Kohler, D. R., Venzon, D. J., and Myers, C. E. Phase I study of phenyl-acetate administered twice daily to patients with cancer. Cancer (Phila.), 75: 2932-2938, 1995.
31. WAF1 is required for survival of differentiating neuroblastoma cells. Mol. Cell. Biol., 16: 1335-1341, 1996.
32. 1 checkpoint control. Cell, 82: 675-684, 1995.
33. Oswald, F., Lovec, H., Moray, T., and Lipp, M. E2F-dependent regulation of human MYC: trans-activation by cyclins D1 and A overrides tumour suppressor protein functions. Oncogene, 9: 2029-2036, 1994.
34. Nevins, J. R. E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science (Washington DC), 258: 424-429, 1992.
35. LaThangue, N. B. DRTF1/E2F: an expanding family of heterodimeric transcription factors implicated in cell cycle control. Trends. Biochem. Sci., 19: 108-114, 1994.
36. Kastan, M. B., Canman, C. E., and Leonard, C. J. p53, cell cycle control and apoptosis: implications for cancer. Cancer Metastasis Rev., 14: 3-15, 1995.
37. Prados, M. D., Spence, A., Schold, C., Mehta, M., Kuhn, J., Rector, D., Chang, S., and Gilbert, M. A Phase II trial of phenylacetic acid for the recurrent malignant glioma, preliminary report of the North American brain tumor consortium. Proc. Am. Soc. Clin. Oncol. Annu. Meet., 288: 156, 1996.
38. Louis, D. N. The p53 gene and protein in human brain tumors. J. Neuropathol. & Exp. Neural., 53: 11-21, 1994.
39. van Meyel, D. J., Ramsay, D. A., Casson, A. G., Keeney, M., Chambers, A. F., and Cairncross, J. G. p53 mutation, expression, and DMA ploidy in evolving gliomas: evidence for two pathways of progression. J. Natl. Cancer Inst., 86: 1011-1017, 1994.
40. Van Meir, E. G., Kikuchi, T., Tada, M., Li, H., Diserens, A. C., Wojcik, B. E., Huang, H. J., Friedmann, T., de Tribolet, N., and Cavenee, W. K. Analysis of the p53 gene and its expression in human glioblastoma cells. Cancer Res., 54: 649-652, 1994.
41. Anker, L., Ohgaki, H., Ludeke, B. I., Herrmann, H. D., Kleihues, P., and Westphal, M. p53 protein accumulation and gene mutations in human glioma cell lines. Int. J. Cancer, 55: 982-987, 1993.
42. Church, G. M., and Gilbert, W. Genomic sequencing. Proc. Natl. Acad. Sci. USA, 81: 1991-1995, 1984.
43. Harlow, E., and Lane, D. Antibodies: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1988.